psoriatic arthritis

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Novartis tests Cosentyx against Humira and biosimilars

https://pharmaphorum.com/news/novartis-tests-cosentyx-humira-biosimilars/

Pfizer’s Xeljanz approved in psoriatic arthritis

https://pharmaphorum.com/news/pfizers-xeljanz-approved-psoriatic-arthritis/

Celgene’s Otezla on course to become blockbuster

https://pharmaphorum.com/news/celgenes-otezla-course-become-blockbuster/

Close in 10 seconds

Pharmaphorum.com

Search